Cronos Group Inc (TSE:CRON) Developing Biosynthesized CBD Products



Cronos Group Inc (TSE:CRON) (NASDAQ:CRON) (FRA:7CI) CEO Mike Gorenstein discusses the global footprint of Cronos and the opportunities legalization presents leading Canadian LPs. Cronos recreational products are available to customers in British Columbia, Nova Scotia, Ontario, and Prince Edward Island while the company’s medical products are available to patients across the country. The company’s Peace Naturals currently supplies medical patients with seeds and clones for home grow. Cronos has a partnership with Ginkgo Bioworks, the largest DNA printer in the world, to sequence Cronos genetics. Once sequenced, products can be replicated at low cost using cannabinoids and terpenes, which have significant implications for the development of new medical treatments. Gorenstein believes Cronos will produce biosynthesized cannabinoids products within 3 years.

************************

Check out our website:

************************

SUBSCRIBE to our YouTube:

SUBSCRIBE to our Newsletter:

Download Our Podcast on iTunes:

************************

Follow Us on Twitter:

Like Us on Instagram:

Like Us on Facebook:

************************

#Cronos
#Cannabis
#WeedStocks

source

Leave a comment

Your email address will not be published.